Our Daniel Jutzi just presented his data on FUS being a unique splicing factor in the RNP dynamics in neurological disease session at the EMBO RNP networks conference in Ljubljana 😍 along with another great talk on FUS and TDP-43 by Magda Polymenidou @PolymenidouLab
Thank you so much to @achrisevans & his listeners, who raised over £300k for @DementiaRev and the UK DRI! 🍾🥳
These vital funds will help our researchers find treatments faster for people with #dementia 🧠🧪
We hope the bidders have an amazing time at @TCSadammarathon!🏃♀️🏃♂️
We're excited to announce the first of our Directors’ Strategic initiatives: A new £2M gene therapy core facility at @KingsUKDRI. Led by Prof Shaw it will realise the potential of adeno-associated virus (AAV), particularly in frontotemporal #dementia. https://t.co/tqSEFHpiVS #FTD
See below for an exciting short statement from Dr. Marc-David Rupp (@UKDRI@KingsIoPPN) regarding his upcoming presentation at the UK-Korea Neuroscience Symposium. Remember to register for the event at https://t.co/K9E5LwQANr
Why not use that Monday motivation to register for the UK Korea #Neuroscience symposium @TheCrick London - 2 days of incredible talks and posters in the heart of London. https://t.co/K9E5LwQANr
Call for abstracts for the 12th UK-KOREA #Neuroscience Symposium @UKorea_Neuro extended until 30th June! 2 days of fantastic talks, promoting collaboration between neuroscience communities in Korea and the UK 🧠 12/13 Aug @TheCrick https://t.co/wDBJpJvXGC
We hope everyone has enjoyed the sunny bank holiday weekend. Why not use this time to submit your abstract for the exciting UK-Korea Neuroscience Symposium taking place @TheCrick. Registration details; https://t.co/E6SRxtycjq #neuroscience
Yessss... at last this is online!! Please come join Marc and myself to generate and characterise new stem cell lines to understand the neurobiology of FTD and ALS. **Deadline 2nd June** 😀😀
Good luck and a massive thank you to all those running today's #Londonmarathon for the #dementiarevolution 🏆 These funds bring us a step closer to breakthroughs in #dementia research and treatments for patients. See you at Mile 25!
Join us and many exciting speakers on the 27th of June 2019 for the @UKDRI at King’s College London (@KingsCollegeLon) “Synapse Symposium: Physiology and Pathophysiology in Synapse”. Please register at https://t.co/b8My7HARXe (limited spaces available).
Abstract Submission for the 12th UK-Korea Neuroscience Symposium is now OPEN! Submit by 31st May 2019 to showcase your #neuroscience research at @TheCrick, London. Accepted abstracts will be considered for short oral presentations. https://t.co/Q7ZVjlpodF
Feels culturally engrained in the biological sciences that we judge experimental results by the "holy grail" of p<0.05.
I still try and nudge students away from this, but it's difficult when such emphasis is put on "significant" findings in publishing
https://t.co/GZFfxIksLj
Major new trial in Huntington’s disease.
“It will take two years to complete, but it should tell us if we have a winner on our hands: a drug that could potentially improve patients’ lives. I am rightly cautious but hopeful.” Prof Sarah Tabrizi @UKDRI@ucl
https://t.co/IRUF3X1Q78
We are excited to announce that Professor Matthew Botvinick, Director of Neuroscience Research at DeepMind (London), will give the plenary lecture “AI and Neuroscience: a virtuous circle?” at the 12th UK-Korea Neuroscience Symposium, @TheCrick London, 12-13th August.